دواعي استعمال ترياكسون 500مجم فيال عضل

Ceftriaxone 500 mg powder for intramuscular injection, single vial (Triaxone, Tabuk Pharmaceutical Manufacturing Company; imported).

• Infections caused by susceptible bacteria: lower respiratory tract, acute otitis media, skin and skin structure, urinary tract, uncomplicated gonorrhoea, pelvic inflammatory disease, bacterial septicaemia, bone and joint, intra-abdominal infections, meningitis; surgical prophylaxis.DailyMed (U.S. National Library of Medicine)

• Known hypersensitivity to ceftriaxone, any excipient or any other cephalosporin.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)
• Premature neonates up to a postmenstrual age of 41 weeks; hyperbilirubinaemic neonates (bilirubin displacement, risk of bilirubin encephalopathy).نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)
• Neonates (28 days or younger) who require or are expected to require calcium-containing IV solutions, including parenteral nutrition, because of ceftriaxone-calcium precipitation.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)
• Intravenous administration of ceftriaxone solutions containing lidocaine.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)

• Hypersensitivity reactions including anaphylaxis; use cautiously in penicillin- or beta-lactam-sensitive patients.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)
• Fatal ceftriaxone-calcium precipitates in lungs and kidneys reported in neonates.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)
• Immune-mediated haemolytic anaemia, including fatal cases; gallbladder pseudolithiasis (ceftriaxone-calcium precipitates), most likely in paediatric patients.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)
• Neurological adverse reactions (encephalopathy, seizures, myoclonus), mostly with severe renal impairment; Clostridioides difficile-associated diarrhoea.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)

• Calcium-containing IV solutionsRisk of ceftriaxone-calcium precipitation; contraindicated in neonates; do not use calcium-containing diluents.DailyMed (U.S. National Library of Medicine)
• Lidocaine (as IM solvent)IV administration of ceftriaxone solutions containing lidocaine is contraindicated; when used as IM solvent, exclude lidocaine contraindications.DailyMed (U.S. National Library of Medicine)

• No embryotoxicity or teratogenicity in animal studies; no adequate well-controlled studies in pregnant women; use only if clearly needed.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)
• Low concentrations are excreted in human milk; use with caution in nursing women.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)